subcutaneous implantable defibrillator (S-ICD) system

DEVICE3 trials

Sponsors

Boston Scientific Corporation

Conditions

ACC/AHA/NASPE Class 1, IIa or IIb IndicationsVentricular FibrillationVentricular TachyarrhythmiasVentricular Tachycardia

Unknown Phase

Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System

CompletedNCT00399217

Boston Scientific CorporationVentricular Fibrillation, Ventricular Tachycardia

Start: 2006-11-30End: 2008-06-30Updated: 2017-02-16

Initial Chronic Human Validation Study: Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System

CompletedNCT00853645

Boston Scientific CorporationVentricular Tachyarrhythmias

Start: 2008-07-31End: 2008-09-30Updated: 2021-07-06

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

CompletedNCT01117792

Boston Scientific CorporationACC/AHA/NASPE Class 1, IIa or IIb Indications

Start: 2008-12-31End: 2009-08-31Updated: 2021-07-02

Related Papers

Longevity of the Subcutaneous Implantable Defibrillator

Circulation Arrhythmia and Electrophysiology2015-07-0744 citations

An entirely subcutaneous implantable cardioverter-defibrillator.

2010-05-12519 citations